Theradome
PrivateLast Round
Crowdfunding
Aug 6, 2013
Total Funding Raised
$1.1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Theradome is a health technology company that develops and manufactures FDA-cleared laser phototherapy helmets for hair restoration and regrowth.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, D2C Brands, E-commerce
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theradome Comparables
Compare Theradome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apira Science, Inc. | 94% | |
| Illumiflow | 93% | |
| Hairmax | 92% |
Theradome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Aug 6, 2013 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 26, 2026
Grew 25% QoQ, from 12 to 15 employees.
- May 19, 2026
Monthly visitors increased 45% MoM.
Theradome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Theradome's valuation, stock price, and market status.
Is Theradome a public or private company?
Theradome is a private company.
What is the current stock price of Theradome?
Theradome is a private company, so its shares have no public market price. Caplight tracks Theradome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Theradome worth (valuation)?
Valuation information for Theradome is not publicly available.
Can I buy Theradome stock?
Theradome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Theradome's last funding round?
Theradome's most recent funding round was Crowdfunding on August 6, 2013.
Who are the main investors in Theradome?
Investor information for Theradome is not publicly disclosed.
Will Theradome IPO soon?
No public IPO plans have been announced for Theradome.
How can I track Theradome secondary market activity?
Caplight tracks bids, offers, and trades in Theradome's shares on secondary markets.